Psyence Biomedical Ltd. (PBM)
4.57
-0.17
(-3.59%)
USD |
NASDAQ |
Oct 13, 16:00
4.57
0.00 (0.00%)
After-Hours: 20:00
Psyence Biomedical Cash and Short Term Investments (Quarterly) : 7.197M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 7.197M |
| September 30, 2024 | 1.962M |
| December 31, 2023 | |
| September 30, 2023 | 0.0882M |
| June 30, 2023 | 0.0098M |
| March 31, 2023 | 0.016M |
| December 31, 2022 | 0.1287M |
| Date | Value |
|---|---|
| September 30, 2022 | 0.2149M |
| June 30, 2022 | 0.3069M |
| March 31, 2022 | 0.4319M |
| December 31, 2021 | 0.6483M |
| September 30, 2021 | 0.0099M |
| June 30, 2021 | 0.01M |
| March 31, 2021 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 930.69M |
| Aurinia Pharmaceuticals, Inc. | 443.12M |
| enGene Therapeutics, Inc. | 266.40M |
| Medicus Pharma Ltd. | 10.70M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |